Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Thursday, January 14, 2010

Phase III Randomized Study of Glutathione for the Prevention of Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in Patients With Ovarian, Fallopi

Phase III Randomized Study of Glutathione for the Prevention of Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in Patients With Ovarian, Fallopian Tube, and/or Primary Peritoneal Carcinoma

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.